We hypothesize that the pro-inflammatory effect of Lp(a) on endothelial cells in COVID-19 patients may be local and connected with atherogenesis, and therefore may not be manifested in CRP or IL-6 serum concentration. This evidence concerns the gene CRP and COVID-19.